Evidence map›Paper›PMID 42865421›Full record

ArticleFrontiers in immunology2026

Molecular basis of anti-CD36 alloimmunization: transcriptomic evidence linking intronic splice-site mutations to CD36 loss-of-function.

Hui Ren, Hong Luo, Haoqiang Ding, Xin Ye, Mingqin Mai, Xinnian Li, Dawei Chen, Yalin Luo, Shengxue Luo, Xiuzhang Xu and 4 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hui Ren *Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Hong Luo *Institute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Haoqiang DingInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Xin YeInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Mingqin MaiMedical Genetics Center, Guangdong Women and Children Hospital, Southern University of Science and Technology, Guangzhou, China.
Xinnian LiGuangzhou Forevergen Medical Laboratory, Guangzhou, China.
Dawei ChenInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Yalin LuoInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Shengxue LuoInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Xiuzhang XuInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Yongmei NieInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Jing WuMedical Genetics Center, Guangdong Women and Children Hospital, Southern University of Science and Technology, Guangzhou, China.
Huaqin LiangInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.
Wenjie XiaInstitute of Blood Transfusion, Guangzhou Blood Center, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: CD36 deficiency is a genetic disorder that can lead to fetal/neonatal alloimmune thrombocytopenia or platelet transfusion refractoriness. While CD36 deficiency caused by exonic mutations are well established, the RNA splicing mechanism by intronic mutations remains poorly defined. Methods: CD36 deficiency patients were analyzed by long-read sequencing and haplotype analysis. RNA sequencing and allele-specific analysis validated mutation-splicing associations in patients. CD36 aberrant transcript plasmids were constructed and assessed by flow cytometry. Exome sequencing of healthy donors determined mutation frequencies. Results: We found that population screening revealed a carrier frequency of approximately 2/800 for c.430-1G>C mutation and ~3/800 for c.429 + 3 Conclusion: This study establishes that intronic mutations alone can also induce CD36 deficiency by impairing mRNA splicing, thereby extending the known mutational landscape of CD36 deficiency and reinforcing the necessity of screening intronic mutations in diagnostic and pathogenetic investigations.

Indexed as

CD36 AntigensIntronsMutationRNA Splice SitesThrombocytopenia, Neonatal AlloimmuneTranscriptomeAllelesExonsFemaleHumansMaleRNA SplicingCD36 AntigensCD36 protein, humanRNA Splice Sitesaberrant transcriptsCD36intron mutationsplice-site varianttype I deficiency

Identifiers

PMID42865421
PMCPMC13654743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.